Join
Live feed
·
INSIDERFilingvia Quantisnow
Cadrenal Therapeutics Inc. logo

Chief Financial Officer Szot Matthew K sold $50,364 worth of shares (3,600 units at $13.99), decreasing direct ownership by 27% to 9,933 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CVKD· Cadrenal Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CVKD (Cadrenal Therapeutics Inc.) and more on Quantisnow.